Search

January 16, 2016 - … we bring to market the first product from our biosimilar pipeline,” said Alpna Seth, Ph. D., Senior Vice President and … we bring to market the first product from our biosimilar pipeline,” said Alpna Seth, Ph. D., Senior Vice President and … we bring to market the first product from our biosimilar pipeline,” said Alpna Seth, Ph. D., Senior Vice President and …

January 27, 2016 - … biosimilar.” “The year ahead will be very exciting for our pipeline, as we look to advance several potential … of R&D programs across its emerging mid- and late-stage pipeline, including aducanumab for Alzheimer’s disease, … EU by Biogen and is the first product from its biosimilar pipeline to be approved. Conference Call and Webcast The …

March 30, 2016 - … infrastructure and approach to support the company’s key pipeline assets. He will report to George Scangos, Ph.D., … to support our increasingly robust and diverse pipeline.” Mr. Vounatsos comes to Biogen after a 20 year … colleagues to deliver on the unique promise of the Biogen pipeline as we seek to transform the lives of patients with …

April 12, 2016 - … the breadth and diversity of its marketed and pipeline multiple sclerosis (MS) therapies at the 68th annual … “With the world’s leading MS portfolio and growing pipeline, Biogen continues to focus on MS care to impact the … the breadth and diversity of its marketed and pipeline multiple sclerosis (MS) therapies at the 68th annual …

April 21, 2016 - … presenting new data supporting the Company’s marketed and pipeline MS therapies at the 68 th American Academy of … statements relating to: Biogen’s commercial business; pipeline and collaboration programs; anticipated data … presenting new data supporting the Company’s marketed and pipeline MS therapies at the 68 th American Academy of …

May 3, 2016 - … priorities specific to their core commercial therapies and pipeline assets; utilize distinct capital allocation … priorities specific to their core commercial therapies and pipeline assets; utilize distinct capital allocation … priorities specific to their core commercial therapies and pipeline assets; utilize distinct capital allocation …

June 21, 2016 - … ran Global Development for Janssen R&D, helping to manage pipeline activities from discovery through clinical … ran Global Development for Janssen R&D, helping to manage pipeline activities from discovery through clinical … ran Global Development for Janssen R&D, helping to manage pipeline activities from discovery through clinical …

July 21, 2016 - … about our science and research as we shape a robust pipeline of novel candidates we believe could have a … operations and he oversaw the enrichment of our product pipeline and the launch of several products. In short, George … development and are in the process of adding to that pipeline even further.” “The Company has an exciting future …

August 1, 2016 - … antisense technology, Ionis has created a large pipeline of first-in-class or best-in-class drugs, with over … antisense technology, Ionis has created a large pipeline of first-in-class or best-in-class drugs, with over … antisense technology, Ionis has created a large pipeline of first-in-class or best-in-class drugs, with over …

August 9, 2016 - … inhibitors. Bioverativ will also focus on advancing pipeline programs that address areas of unmet need in … inhibitors. Bioverativ will also focus on advancing pipeline programs that address areas of unmet need in … inhibitors. Bioverativ will also focus on advancing pipeline programs that address areas of unmet need in …